Yusuf Serhat İş

Proposing Novel MAO-B Hit Inhibitors Using Multidimensional Molecular Modeling Approaches and Application of Binary QSAR Models for Prediction of Their Therapeutic Activity, Pharmacokinetic and Toxicity Properties

Yusuf Serhat İş, Serdar Durdağı, Busecan Aksoydan et al. · ACS Chemical Neuroscience · 2018 · 33 citations

A QM protein–ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R)

Ramin Ekhteiari Salmas, Yusuf Serhat İş, Serdar Durdağı et al. · Journal of Biomolecular Structure and Dynamics · 2017 · 15 citations · Full text

Drug Target, Psychotropic Medication, Psychopharmacology +26

Integrated Binary QSAR-Driven Virtual Screening and In Vitro Studies for Finding Novel hMAO-B-Selective Inhibitors

Yusuf Serhat İş, Busecan Aksoydan, Murat Şentürk et al. · Journal of Chemical Information and Modeling · 2020 · 10 citations

Deciphering the mechanism and binding interactions of Pemetrexed with dsDNA with DNA-targeted chemotherapeutics via spectroscopic, analytical, and simulation studies

Pelin Şenel, Soykan Ağar, Yusuf Serhat İş et al. · Journal of Pharmaceutical and Biomedical Analysis · 2021 · 10 citations